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Introduction
Enterococci are normal inhabitant bacteria of
human and animal gastrointestinal tracts, but in
the past decade Enterococcus faecalis and
Enterococcus faecium have emerged as
important pathogens responsible for hospital-
acquired infections [1,2].The importance of these
bacteria has increased with the occurrence of
high-level resistance to multiple antimicrobial
drugs, such as vancomycin [3, 4].The first clinical
strains of Vancomycin-Resistant Enterococci
(VRE) were isolated in England and France in
1986, and one year later in the US. After these
outbreaks the genetic mechanism for vancomycin
resistance was studied and associated to mobile
elements,which can potentially be transmitted to
other Gram-positive bacteria, such as methicillin-
resistant Staphylococcus aureus (MRSA) [1, 5].
The antibiotic resistance is determined by
different genotypes, which lead to the production
of cell-wall precursors with low affinity for
glycopeptides. Six molecular mechanisms, labelled
as VanA, VanB, VanC, VanD, VanE and VanG were
identified in enterococci. VanA and VanB
phenotypes are dominant in Europe and inAmerica
and are more clinically relevant. Both phenotypes
derive from acquisition of genetic determinants of
resistance carried on transposon Tn 1546, while
other types of resistance are constitutive. VanA-
positive enterococci show high-level resistance to
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Abstract
Background: In the last decades vancomycin-resistant enterococci (VRE) have emerged as important
pathogens responsible for hospital-acquired infections. To analyze the spread and clonal relatedness of VRE,
a two-year study of isolates was carried out in the hospital of the University “Federico II” in Naples.
Methods: Enterococcus species were identified by using API-20 Strep and antibiotic susceptibility was
determined through the use of four tests: disk diffusion, broth dilution methods, Etest and Vitek 2.
Polymerase Chain Reaction (PCR) was used to analyse glycopeptide resistance. Pulsed-field gel
electrophoresis (PFGE) and arbitrarily primed (AP)-polymerase chain reaction were used for molecular
typing of the strains.
Results: Thirty-two isolates of enterococci (18 E. faecium and 14 E. faecalis) showed resistance to
vancomycin and teicoplanin and all the strains were vanA-positive. AP-PCR showed a unique clone of E.
faecium, as well as for E. faecalis isolates. Identical results were obtained by PFGE for E. faecalis isolates,
while three different PFGE patterns emerged for E. faecium.
Conclusions: The low degree of genetic diversity among the isolates strongly suggests a clonal spread of
antibiotic-resistant strains among hospitalized patients in high-risk wards.
This report represents the first step to understanding VRE spread in our hospital as well as contributing to
the comparison among different antibiotic susceptibility tests and molecular typing methods.
Keywords: vancomycin-resistant enterococci, antibiotic susceptibility, genotyping, PFGE, AP-PCR.
vancomycin and teicoplanin; VanB-positive
enterococci are resistant to vancomycin and
susceptible to teicoplanin [1, 2, 4, 5].
Valid and rapid methods to detect vancomycin
resistance and to establish the clonality of isolates
are fundamental in order to set up effective
infection control strategies. Several laboratory
methods for the detection of glycopeptides
resistance are available today. Some authors,
however, report the failure of certain automated
susceptibility tests [6],while other studies account
for the sensitivity of new automated systems [7].
Although Pulsed-Field Gel Electrophoresis (PFGE)
is generally acknowledged as the method of choice
for typing isolates in most epidemiological
investigations, Arbitrarily Primed – Polymerase
Chain Reaction (AP-PCR) is much faster, but it is
much more susceptible to technical variations and
should be carefully evaluated before its
introduction for surveillance purposes [8].
The aim of this study was to investigate the
spread and the clonal relatedness of vancomycin-
resistant enterococci isolated in an Italian
University hospital during the years 2003 – 2005,
by employing phenotypic and genotypic tests.
Vancomycin resistance phenotype was detected
using three currently available commercial
methods, and compared to a disk diffusion screen
method. Furthermore, PCR for the Van genotype
was performed and compared with phenotypic
tests.At last, all VRE strains were genotyped with
two molecular methods to determine the
relationships among them.
Methods
Phenotypic characterization
During the period May 2003 – Jan 2005, all
Enterococcus spp. isolated from patients admitted
to the University hospital “Federico II” in Naples
were collected and typed with phenotypic and
genotypic methods.Only the first isolate from each
patient was included in the analysis. The strains
were identified by API 20 Strep system
(bioMérieux, France) and their susceptibility to
vancomycin (Van) and teicoplanin (Tei) was tested
through the use of four methods. Screening was
performed using the Kirby Bauer test on Mueller
Hinton agar with disks containing 30 µg ofVan and
30 µg of Tei (Oxoid SpA, Italy). Resistance was
revealed by a diameter of inhibition zone < 14 mm
for Van and < 10 mm for Tei [9]. The Etest (AB
Biodisk,Sweden/Biolife Italiana srl) was carried out
on Brain Heart Infusion agar, with a 0.016-256
µg/mL concentration range for both antibiotics.
The Sensititre test (Biomedical Service srl,Venice,
Italy) was performed in Mueller Hinton broth on
multi-well plates containing Van (0.5-16 g/mL) and
Tei (0.5-32 g/mL). Finally, the resistance to Van and
Tei was evaluated by the Vitek 2 system
(bioMérieux, France),with AST-P516 susceptibility
cards. The MIC breakpoints were considered as
follows: Van, < 4 mg/mL for susceptible, 8 to 16
mg/mL for intermediate, and > 32 mg/mL for
resistant;Tei, < 8 mg/mL for susceptible, 16 mg/mL
for intermediate, and > 32 mg/mL for resistant [9].
Molecular characterization
For each enterococcal strain which showed
resistance to vancomycin and teicoplanin,two PCRs
were set up. The first one contained primers
VanABF, VanAR, and VanBR, which allow the
amplification of 231 and 330 bp fragments from the
vanA and vanB genes, respectively. The second
reaction was performed with primers VanC1F,
VanC1R,VanC23F,andVanC23R,which allow for the
amplification of 447 and 597 bp fragments; both
fragments are amplified from the vanC1 gene or
from the vanC2 and vanC3 gene,respectively.All the
reactions were carried out with 200 M dNTP, 1 M
each primer and 1 U ofTaq polymerase (Boehringer
Mannheim).The amplification protocol included 35
cycles, as following: 1 min at 94°C; 2 min at 60°C; 2
min at 72°C. Electrophoresis was carried out in a
1.5% agarose gel.TheVRE genotype was determined
on the basis of the size of amplification product.
All the VRE strains were characterized through
AP-PCR by using the 8F primer, as previously
published [10]. The preparation of genomic DNA
for PFGE was performed as previously described
[11]. DNA restriction was done with SmaI
according to the manufacturer’s recommendations
(New England Biolabs). PFGE gels were run in a
CHEF-DR II apparatus (BioRad) using the following
conditions: run time, 26 h; temperature, 7 °C;
voltage, 200 V; initial forward time, 5 sec; final
forward time, 35 sec.
Results
Between May 2003 and January 2005,488 clinical
isolates of Enterococcus spp.were collected as part
of the routine diagnostic microbiology services in
the University hospital “Federico II”,Naples.Thirty-
two (6.5%) of 488 isolates showed resistance to
vancomycin and were included in the analysis. In
particular,18 (12.5%) of the E. faecium isolates and
14 (4%) of the E. faecalis isolates were VRE. The
epidemiological and molecular features of the 32
VRE isolates are showed in Table I. All VRE were
isolated in three wards: the Intensive Care Unit
(ICU) (15 isolates of 32, 46.9%), the haematology
unit (9 of 32, 28.1%) and the nephrology unit (8 of
32, 25%). VRE isolates originated from urine
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cultures (53.1%), respiratory materials, such as
throat swabs, sputum or pleuric fluid (28.1%), as
well as blood and vascular catheters (18.8%).
All isolates were shown to be resistant to high
doses of vancomycin (MIC > 128 mg/mL) as well
as being resistant to teicoplanin in at least three of
four used susceptibility tests, always with MIC >
16 mg/mL (data not shown). All VRE isolates
belonged to the vanA genotype.
AP-PCR typing showed a clonal relatedness
within E. faecium and E. faecalis isolates,
respectively. All 18 E. faecium isolates showed an
identical pattern (Y), while a different pattern (X)
was shown by all the 14 E. faecalis isolates (Fig. 1).
PFGE after restriction with SmaI resolved the
genomic DNA of the 18 E.faecium isolates into four
distinct PFGE patterns,that differed in migration for
at least four DNA fragments. PFGE pattern B
represented the main clone, since it was shown by
eight isolates from ICU [3] and the haematology
unit [5], followed by PFGE pattern C, which was
found in five isolates from IUC and in one isolate
from the haematology unit. PFGE pattern D,which
could be further classified into two sub-types (D1
and D2) was represented by three isolates from the
three wards,whereas PFGE pattern E was shown in
a single isolate from the nephrology unit.All 14 E.
faecalis isolates belonged to the same PFGE pattern
(A) (Figure 2). It is noteworthy that both in the ICU
and in haematology unit it was possible to isolate all
the four major VRE clones found in this study,
whereas the nephrology unit was characterized by
the clonal spread of E. faecalis, that occurred
together with two sporadic isolations of E.
faecium.
Discussion
The epidemiology of VRE infection differs
between Europe and the United States. In the
United States, nosocomial VRE infections and
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Epidemiological data
Code Date (yr/mo/day) Patient location Specimen Species Genotype AP-PCR pattern PFGE pattern
30 03.05.23 ICU* Urine E. faecalis Van A X A
16 03.10.01 ICU* Pleuric fluid E. faecalis Van A X A
17 03.10.08 ICU* Catheter E. faecalis Van A X A
1 03.11.02 ICU* Urine E. faecalis Van A X A
7 04.01.25 ICU* Urine E. faecalis Van A X A
9 04.02.01 ICU* Urine E. faecalis Van A X A
27 03.05.30 ICU* Urine E. faecium Van A Y C
26 03.06.20 ICU* Urine E. faecium Van A Y C
2 03.08.08 ICU* Urine E. faecium Van A Y C
12 03.09.02 ICU* Sputum E. faecium Van A Y B
13 03.10.04 ICU* Catheter E. faecium Van A Y B
29 03.10.07 ICU* Urine E. faecium Van A Y C
25 03.11.05 ICU* Urine E. faecium Van A Y D1
3 03.11.17 ICU* Blood E. faecium Van A Y C
10 04.02.07 ICU* Urine E. faecium Van A Y B
11 03.09.02 Nephrology Urine E. faecalis Van A X A
6 03.09.21 Nephrology Sputum E. faecalis Van A X A
4 03.07.24 Nephrology Throat swab E. faecalis Van A X A
19 03.10.25 Nephrology Urine E. faecalis Van A X A
18 03.10.26 Nephrology Urine E. faecalis Van A X A
22 03.11.22 Nephrology Catheter E. faecalis Van A X A
24 03.11.16 Nephrology Sputum E. faecium Van A Y D1
31 03.11.18 Nephrology Catheter E. faecium Van A Y E
20 04.10.26 Haematology Throat swab E. faecalis Van A X A
28 04.12.28 Haematology Urine E. faecalis Van A X A
32 04.07.05 Haematology Blood E. faecium Van A Y D2
21 04.09.05 Haematology Urine E. faecium Van A Y C
15 04.09.28 Haematology Throat swab E. faecium Van A Y B
14 04.10.05 Haematology Throat swab E. faecium Van A Y B
23 04.12.17 Haematology Urine E. faecium Van A Y B
5 05.01.11 Haematology Urine E. faecium Van A Y B
8 05.01.25 Haematology Throat swab E. faecium Van A Y B
Table 1. source and date of isolation, species identification, genotype, AP-PCR and PFGE patterns of the 32 VRE isolates.
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Figure 1. results of AP-PCR performed on the 32 VRE isolates with primer 8F. Enterococcus faecalis isolates (n. 1, 4, 6, 7, 9, 11, 16-
20, 22, 28 and 30) show a similar pattern, while Enterococcus faecium isolates (n. 2, 3, 5, 8, 10, 12-15, 21, 23-27, 29, 31, 32) show
another pattern. M: molecular weight marker.
Figure 2. SmaI PFGE patterns of VRE isolates, representative gel. Lanes 1 to 6, Enterococcus faecium isolates. Lanes 7 to 12,
Enterococcus faecalis isolates. M: molecular weight marker.
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transmission has occurred much more frequently
than in the Europe [1, 12]. From 1989 to 1999, the
National Nosocomial Infection Surveillance
(NNIS) System of the Centers for Disease Control
and Prevention reported an increase in the
percentage of VRE associated with nosocomial
infections in ICU from 0.4% to 25.2% [13]. In
Europe, hospital infections due to VRE are still
relatively uncommon, although VRE strains are
common in the intestinal flora of healthy humans
and farm animals [1, 14].
Nevertheless, the European Antibiotic
Resistance Surveillance System (EARSS) reported
in Italy a percentage of VRE among enterococcal
clinical isolates higher than 10% in 2001 and
2002.The proportion of VRE among bloodstream-
infecting E. faecium isolates in 2002 (19%) was
one of the highest in Europe, while the
percentage of VRE among bloodstream-infecting
E. faecalis isolates (4%) was similar to the average
matched in the other European countries
(http://www.earss.rivm.nl/).The high prevalence
of VRE in Italy was also confirmed by another
European study carried out in 2001 in at-risk
hospital wards, where Italy and the United
Kingdom reported the highest rates of VRE, 10.4
and 19.6%, respectively [15]. In the last decades,
several hospital outbreaks and the endemic
spread of genetically related VRE strains were
reported in Italy [16-20].
The spread of VRE infections in health-care
institutions involves person-to-person
transmission and selective antibiotic pressure [2].
In 1995, the Hospital Infection Control Practices
Advisory Committee (HICPAC) published
recommendations for preventing the spread of
vancomycin resistance, which include
surveillance for colonization, identification of
colonized and infected patients, isolation or
cohorting of colonized patients, use of gloves and
gowns, room cleaning after patient discharge, and
limited use of vancomycin in therapy [2, 21].
In order to improve the role of surveillance in the
control of VRE infections, the microbiology
laboratories have to optimize their ability to rapidly
detect VRE as well as clonal relatedness of isolates.
Several studies have been done assessing the
accuracy of various antimicrobial susceptibility
methods in detecting vancomycin resistance in
enterococci:some authors reported that automated
methods (i. e. Vitek system) accounted for good
sensitivity and specificity, while in other studies
agar-diffusion or traditional broth microdilution
methods showed higher reliability [6,7,22,23].
Comparative analyses of AP-PCR and PFGE for
genetic typing of VRE are still relatively scarce:
while some studies reported thatAP-PCR analysis is
well-suited for the epidemiological typing of VRE,
there are concerns about the reproducibility of the
method [24-26].
This report was carried out in order to analyze
vancomycin-resistant enterococci isolated in the
University hospital “Federico II” in Naples, during a
two-year period. A low prevalence of VRE strains
was registered in this hospital, and the spread was
limited to three wards: intensive care, haematology
and nephrology units. The prevalence of
vancomycin resistance among both faecium and
faecalis species of 12.5% and 4% respectively, is
similar to that reported in the national data [16].
However, the clonal relatedness detected among E.
faecium isolates and especially among E. faecalis
isolates which was shown by AP-PCR and PFGE,
indicates the transmission of these multiresistant
strains among hospitalized patients and the need of
an improvement in infection control.
The application of HICPAC guidelines, through
the limitations of vancomycin use,performance of
surveillance cultures and improved infection
control measures, has shown good efficacy in
several epidemic outbreaks [27, 28]. In a more
recent study carried out in the Netherlands, a
program based on preemptive isolation,
genotyping analyses, identification of VRE carriers
and enhancement of hand-hygiene compliance
was successful in the control of nosocomial
spread of VRE infections [29].
Many epidemiological surveillance programs
carried out with molecular genotyping have
shown that sporadic spread introduction of VRE
in the hospital through admission of colonized
patients may lead to small outbreaks caused by
single clones and thus to a polyclonal endemicity
state. For each stage different infection control
measures could be applied [1]. In order to prevent
the development of endemicity in those units in
whichVRE strains were isolated in our institution,
an improvement of hospital hygiene through
educational programs for the personnel staff, a
more responsible use of antibiotics, culture
surveillance of high-risk patients and isolation of
VRE-colonized patients should be adopted.
With regards to the methods used to check the
antimicrobial susceptibility of strains, they
produced similar results, confirming their
usefulness. All of these methods, which are
commonly used for routine analysis, showed a
good level of sensitivity referring to the screening
method and were easy to use. Accordance
between results obtained with Vitek 2 and other
methods may also enhance the use of this
automated, more rapid test. Moreover, the
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correlation between the results of genotypic and
phenotypic characterization of glycopeptide
resistance, demonstrated the usefulness of PCR to
analyze the molecular mechanisms of
susceptibility and the accuracy of Etest, Sensititre
test and AST-P516 cards for detection of vanA-
positive strains. However, due to the absence of
other genotypes among our strains, these results
are limited. The presence of one genotype may
also account for a clonal diffusion of this
resistance determinant.
PFGE is currently considered the “gold
standard” for VRE typing, but it is time-consuming
and requires specific equipment. PCR-based
techniques,such asAP-PCR,are faster and easier to
perform. However, the results of our comparative
evaluation clearly show that the discriminatory
power of PFGE is higher than that of AP-PCR,
since it was able to screen four different patterns
among E. faecium isolates. These different PFGE
patterns were identified using the three bands
difference criterion proposed by Tenover et al.; it
is interesting to note that, even using a less strict
six bands difference criterion, as recently
proposed by some authors, the results would have
been the same [30, 31].The lower discriminatory
power of AP-PCR compared to PFGE has been
shown by other investigators [25, 26]
In conclusion, the results of this study clearly
show that susceptibility tests, such as Etest,
Sensitre test and Vitek 2 with AST-P5151 cards are
useful to detectVanA-positive strains of E. faecium
and E. faecalis and that PFGE, but not AP-PCR,
could be used to identify clonal spread of isolates.
Therefore, the combined use of these techniques
is fundamental to identify the need for specific
control measures against VRE.
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